• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞条件培养基通过激活肝癌细胞中的ERK1/2信号通路诱导增殖和上皮-间质转化

[Hepatic stellate cell conditioned medium induces proliferation and epithelial-mesenchymal transition via activating ERK1/2 signaling pathway in hepatoma cells].

作者信息

Xie Yuxiao, Liao Rui, Pan Long, Fan Kai, Peng Cong, Du Chengyou

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Feb;33(2):210-4.

PMID:29762991
Abstract

OBJECTIVE

To investigate the influence of hepatic stellate cells( HSCs) on malignant biological behavior of hepatoma cells and related mechanisms.

METHODS

Human hepatoma cell lines SMMC-7721 and Hep G2,and hepatic stellate cell line LX-2 were cultured separately. HSC conditioned medium( LX2-CM),MAPK specific inhibitor U0126 were used to treat hepatoma cells,separately or together. The invasion and migration abilities of hepatoma cells were detected by TranswellTMassay,and cell proliferation was analyzed by CCK-8 assay. The mRNA and protein expression levels of p-ERK1 /2,ERK1 /2,c-Myc,vimentin and E-cadherin were determined by real-time PCR and Western blot analysis,respectively.

RESULTS

LX2-CM promoted the proliferation,invasion and migration of SMMC-7721 and Hep G2 cells,and these effects were inhibited by U0126. LX2-CM up-regulated the expression levels of p-ERK1 /2,c-Myc,vimentin and down-regulated the expression level of E-cadherin. Conversely,after U0126 treatment,the expression levels of p-ERK1 /2,c-Myc and vimentin decreased significantly,while E-cadherin expression level increased.

CONCLUSION

LX2-CM could activate c-Myc via ERK1 /2signaling pathway in hepatoma cells,and consequently promote cell proliferation,invasion and migration,and also induce epithelial-mesenchymal transition.

摘要

目的

探讨肝星状细胞(HSCs)对肝癌细胞恶性生物学行为的影响及其相关机制。

方法

分别培养人肝癌细胞系SMMC-7721和Hep G2以及肝星状细胞系LX-2。用肝星状细胞条件培养基(LX2-CM)、丝裂原活化蛋白激酶(MAPK)特异性抑制剂U0126单独或联合处理肝癌细胞。采用TranswellTM实验检测肝癌细胞的侵袭和迁移能力,用CCK-8实验分析细胞增殖情况。分别通过实时荧光定量PCR和蛋白质免疫印迹法检测p-ERK1 /2、ERK1 /2、c-Myc、波形蛋白和E-钙黏蛋白的mRNA及蛋白表达水平。

结果

LX2-CM促进SMMC-7721和Hep G2细胞的增殖、侵袭和迁移,而U0126可抑制这些作用。LX2-CM上调p-ERK1 /2、c-Myc、波形蛋白的表达水平,下调E-钙黏蛋白的表达水平。相反,U0126处理后,p-ERK1 /2、c-Myc和波形蛋白的表达水平显著降低,而E-钙黏蛋白表达水平升高。

结论

LX2-CM可通过ERK1 /2信号通路激活肝癌细胞中的c-Myc,进而促进细胞增殖、侵袭和迁移,并诱导上皮-间质转化。

相似文献

1
[Hepatic stellate cell conditioned medium induces proliferation and epithelial-mesenchymal transition via activating ERK1/2 signaling pathway in hepatoma cells].肝星状细胞条件培养基通过激活肝癌细胞中的ERK1/2信号通路诱导增殖和上皮-间质转化
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Feb;33(2):210-4.
2
ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.细胞外信号调节激酶(ERK)通路的激活有助于肝星状细胞在肝细胞癌中发挥促肿瘤作用。
Immunol Lett. 2017 Aug;188:116-123. doi: 10.1016/j.imlet.2017.06.009. Epub 2017 Jun 28.
3
Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.微小RNA-16对肝癌细胞增殖、侵袭和转移的抑制作用。
Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.
4
Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.骨桥蛋白参与亚致死热疗后激活的肝星状细胞诱导残余肝细胞癌的进展:其作用和治疗抑制的潜力。
J Transl Med. 2018 Nov 6;16(1):302. doi: 10.1186/s12967-018-1676-3.
5
Multi-omics analysis reveals mechanism of Schisandra chinensis lignans and acteoside on EMT in hepatoma cells via ERK1/2 pathway.多组学分析揭示了五味子木脂素和獐牙菜苷通过 ERK1/2 通路诱导肝癌细胞 EMT 的机制。
Funct Integr Genomics. 2024 Jun 8;24(3):112. doi: 10.1007/s10142-024-01351-w.
6
Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)通过MEK/ERK信号通路下调E-钙黏蛋白并诱导肝癌细胞发生上皮-间质转化,从而促进肝细胞癌转移。
J Dig Dis. 2017 Jun;18(6):349-358. doi: 10.1111/1751-2980.12486.
7
[The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].[miR-130b在人肝细胞癌中的表达及临床病理意义]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Mar;32(3):387-92.
8
HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.HSCs 衍生的 COMP 通过激活 MEK/ERK 和 PI3K/AKT 信号通路促进肝细胞癌进展。
J Exp Clin Cancer Res. 2018 Sep 19;37(1):231. doi: 10.1186/s13046-018-0908-y.
9
Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.长链非编码RNA SPRY4-IT1的过表达通过激活肝细胞癌中的EZH2促进肿瘤细胞增殖和侵袭。
Biomed Pharmacother. 2017 Jan;85:348-354. doi: 10.1016/j.biopha.2016.11.035. Epub 2016 Nov 28.
10
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451:上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.

引用本文的文献

1
[Effect of conditioned medium of vascular endothelial cells on the epithelial-mesenchymal transition of hepatocellular carcinoma cells].[血管内皮细胞条件培养基对肝癌细胞上皮-间质转化的影响]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Jun 25;37(3):442-449. doi: 10.7507/1001-5515.201907041.
2
Tripartite Motif Containing 11 Interacts with DUSP6 to Promote the Growth of Human Osteosarcoma Cells through Regulating ERK1/2 Pathway.三肽基含 11 蛋白与 DUSP6 相互作用通过调节 ERK1/2 通路促进人骨肉瘤细胞的生长。
Biomed Res Int. 2019 Dec 25;2019:9612125. doi: 10.1155/2019/9612125. eCollection 2019.
3
Baicalin and puerarin reverse epithelial-mesenchymal transition via the TGF-β1/Smad3 pathway .
黄芩苷和葛根素通过TGF-β1/Smad3信号通路逆转上皮-间质转化。
Exp Ther Med. 2018 Sep;16(3):1968-1974. doi: 10.3892/etm.2018.6400. Epub 2018 Jul 4.
4
Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells.在人肝星状细胞中表现出抗纤维化作用。
Evid Based Complement Alternat Med. 2017;2017:3508569. doi: 10.1155/2017/3508569. Epub 2017 Dec 13.